Ligand validation:2I5J

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 2I5J designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2I5J_GLC_A_2002	21%	62%	0.239	0.849	0.59	0.85	-	1	0	0	100%	1
2I5J_GLC_A_2001	10%	54%	0.358	0.87	0.56	1.2	-	2	3	0	100%	1
2I5J_GLC_B_2003	5%	59%	0.376	0.781	0.76	0.81	-	1	1	0	100%	1
1R0A_GLC_H_1725	46%	67%	0.163	0.898	0.61	0.67	-	-	2	0	100%	1
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	1
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.64
8R53_GLC_A_901	98%	61%	0.047	0.969	0.78	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.